Prostate Cancer - Results from #27220

Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy - Abstract August 26, 2011

Prostate cancer knowledge in Irish men - Abstract August 26, 2011

Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones - Abstract August 26, 2011

The human female prostate-immunohistochemical study with prostate-specific antigen, prostate-specific alkaline phosphatase, and androgen receptor and 3-D remodeling - Abstract August 26, 2011

Genetic variation in base excision repair pathway genes, pesticide exposure, and prostate cancer risk - Abstract August 26, 2011

German Network for Congenital Uro-REctal Malformations: First evaluation and interpretation of postoperative urological complications in anorectal malformations - Abstract August 26, 2011

Robot assisted radical prostatectomy for elderly patients with high risk prostate cancer - Abstract August 25, 2011

Pemetrexed as second-line chemotherapy for castration-resistant prostate cancer after docetaxel failure: Results from a phase II study - Abstract August 25, 2011

Colorectal, prostate, and skin cancer screening among Hispanic and White non-Hispanic men, 2000-2005 - Abstract August 25, 2011

PET and PET/CT in radiation treatment planning for prostate cancer - Abstract August 25, 2011

Current status of transurethral prostatectomy: A Korean multicenter study - Abstract August 25, 2011

Holmium laser enucleation versus bipolar resection of the prostate: A prospective randomized study. Which to choose? - Abstract August 24, 2011

Prostate cancer and vitamin D: What does the evidence really suggest? - Abstract August 24, 2011

The correlation among the percentage of positive biopsy cores from the dominant side of prostate, adverse pathology, and biochemical failure after radical prostatectomy - Abstract August 24, 2011

Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer - Abstract August 24, 2011

The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance - Abstract August 24, 2011

Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy - Abstract August 24, 2011

Automatic segmentation of radiographic fiducial and seeds from X-ray images in prostate brachytherapy - Abstract August 24, 2011

EDAP partnership wins EUR 2.4 million grant for development of innovative imaging solution for focal treatment of prostate cancer August 24, 2011

Editor's Commentary - The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention August 24, 2011

Page 1362 of 1434